Kevin Zeitler

Right Guard

Age: 30
Free Agency: 2022 (UFA)
Accrued Seasons: 8
  • 2020 Salary Cap Charge: $12,500,000 (6.33% of cap)
  • 2020 Cash Payout: $10,000,000 (5.97% of spending)
  • 2020 Cash to Cap Ratio: 0.80
  • Contract Value: $60,000,000 ($12,000,000 APY)
  • Fully Guaranteed Money: $23,000,000
  • Contract Ranking: 4/97 at RG

Current Contract

(UFA, signed 2017)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
201929$2,500,000$2,500,000$3,500,000$5,000,0002.6%
202030$10,000,000$2,500,000$0$12,500,0006.3%
202131$12,000,000$2,500,000$0$14,500,0006.7%
Total$24,500,000$7,500,000$3,500,000$32,000,000

Contract Notes

Per report from Field Yates the New York Giants restructured Zeitler's contract converting $7.5 million of his 2019 base salary into a signing bonus.  The adjustment created a $5 million cap savings for 2019; and increases Zeitler's cap charges in 2020 & 2021 by $2.5 million each.The Browns traded Zeitler to the Giants. The trade will be official on March 13, 2019.Kevin Zeitler signed a five year, $60 million contract with the Browns on March 11, 2017. Zeitler recieved $23 million guaranteed at signing including a $12 million signing bonus. The contract has $31.5 million in total guarantees, the balance of which will become fully guaranteed in 2018.
Career Earnings: $53,614,200
Career APY: $6,701,775
Potential Earnings: $75,614,200
Total Guarantees: $52,125,446
Largest Cash Payment: $18,000,000 (2017)
Largest Cap Number: $14,500,000 (2021)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
BengalsDraftedExpired20125$15,614,200$3,122,840$6,125,446$15,614,200100.0%$3,122,840
GiantsUFAActive20175$60,000,000$12,000,000$23,000,000$10,000,00016.7%$10,000,000
BrownsUFATraded20175$60,000,000$12,000,000$23,000,000$28,000,00046.7%$14,000,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Bengals5$15,614,200$3,122,840$15,614,2000.0%$00.0%
Giants1$10,000,000$10,000,000$5,000,0000.0%$00.0%
Browns2$28,000,000$14,000,000$20,800,0000.0%$7,200,0000.0%

Salary Cap History

YearTeamBase SalaryProrated BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2012Bengals$390,000$981,673$0$1,371,6731.1%$4,316,692
2013Bengals$732,918$981,673$732,918$1,714,5911.3%$732,918
2014Bengals$1,075,836$981,673$1,075,836$2,057,5091.5%$1,075,836
2015Bengals$1,418,754$981,673$0$2,400,4271.6%$1,418,754
2016Bengals$8,070,000$0$8,070,000$8,070,0004.9%$8,070,000
2019Giants$2,500,000$2,500,000$3,500,000$5,000,0002.6%$10,000,000
2020Giants$10,000,000$2,500,000$0$12,500,0006.3%$10,000,000
2021Giants$12,000,000$2,500,000$0$14,500,0006.7%$12,000,000
2017Browns$6,000,000$2,400,000$6,000,000$8,400,0003.9%$18,000,000
2018Browns$10,000,000$2,400,000$10,000,000$12,400,0005.1%$10,000,000
Total$52,187,508$16,226,692$29,378,754$68,414,200$75,614,200
Dead Money History
TeamYearCap ChargeCash Paid
Browns2019$7,200,000$0
Total$7,200,000$0

Statistics

YearGames PlayedGames MissedSnaps
InjuredHealthyOffenseSpecial
201216----99.4%16.8%
2013122071.5%12.4%
2014124069.4%9.9%
2015160098.7%16.9%
20161600100.0%15.8%
20171600100.0%10.6%
20181600100.0%12.9%
2019151092.9%11.3%

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$7,751,000$12,000,000
Injury Adjusted$8,273,104$11,250,000
test
OTC Valuation $1.9M $3.8M $5.7M $7.7M $9.6M APY $2.5M $5.0M $7.5M $10.0M $12.5M $4,059,000 $4,500,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.